Results 211 to 220 of about 70,470 (286)

NT-proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point-of-Care and Remote Monitoring. [PDF]

Respirology
Durrington C, Battersby C, Holt L, Fairman A, Strickland S, Salisbury T, Turton HA, Watson L, Smith I, Roman S, Ablott J, Hitchcock F, Roddis C, Oakes E, Wilshaw H, Woodrow I, Armstrong I, Charalampopoulos A, Elliot CA, Hameed A, Hamilton N, Hurdman JA, Lawrie A, Middleton JT, Zafar H, Rothman AMK, Condliffe R, Lewis RA, Kiely DG, Thompson AAR.   +29 more
europepmc   +1 more source

Acceptability of Cardiovascular Disease Point‐of‐Care Diagnostics in Primary Care Settings: A Scoping Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Cardiovascular disease (CVD) remains the leading global cause of death, with 80% of deaths occurring in low‐ and middle‐income countries (LMICs). Improving access to screening and early diagnosis is essential. Point‐of‐care testing (POCT), which provides rapid results near the patient, is particularly valuable in resource ...
Nakedi Moswete, Siphesihle Robin Nxele, Penelope Modipane, Evans Duah, Bettina Chale‐Matsau, Gabrielle Thompson, Tivani Mashamba‐Thompson   +6 more
wiley   +1 more source

Lower NT-proBNP plasma concentrations in Pacific peoples with heart failure. [PDF]

ESC Heart Fail
Pearson AG, Pearson JF, Lewis LK, Fa'atoese A, Poppe KK, Pemberton C, Devlin G, Lund M, Richards AM, Troughton R, Doughty RN.   +10 more
europepmc   +1 more source

Comparative prognostic value of high-sensitivity cardiac troponin T and NT-proBNP for 30-day mortality in non-cardiac critically ill patients. [PDF]

Sci Rep
Świstek R, Szpunar W, Droś J, Konieczyński J, Kasongo P, Kwinta A, Lonc T, Drygalski T, Jarczyński M, Chlubek A, Narożniak M, Iskrzyński D, Orzechowska D, Terlecki M.   +13 more
europepmc   +1 more source

Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics

MedComm, Volume 7, Issue 3, March 2026.
In HOMAGE, 276 plasma proteins were profiled using Olink panels. Machine learning algorithms identified galectin‐9 (GAL9), thrombospondin‐2 (THBS2), and NT‐proBNP as predictors of changes in procollagen type I C‐terminal propeptide (PICP) after spironolactone treatment.
Susana Ravassa, Nicolas Girerd, Frank Edelman, Begoña López, João Pedro Ferreira, Daniela Zurkan, Gorka San José, Iñigo Latasa, Pierpaolo Pellicori, Franco Cosmi, Johannes Petutschnigg, Stephane Heymans, Hans‐Peter Brunner‐La Rocca, Burkert Pieske, Christian Delles, Andrew L. Clark, Javier Díez, Faiez Zannad, John G. F. Cleland, Arantxa González, the HOMAGE Trial Committees and Investigators   +20 more
wiley   +1 more source

Association between NT-proBNP and ivabradine in patients after noncardiac surgery: a per-protocol analysis of the PREVENT-MINS study. [PDF]

Anaesthesiol Intensive Ther
Gorka J, Putowski Z, Wludarczyk A, Jedrusiak M, Bialka S, Palaczynski P, Borys M, Kutnik P, Czarnik T, Szczepanska A, Wawrzyniak S, Mozanski M, Keska M, Kotfis K, Trzebicki J, Aszkielaniec J, Solek-Pastuszka J, Grudzien P, Mudyna W, Kreczko M, Zhao Z, Devereaux PJ, Szczeklik W.   +22 more
europepmc   +1 more source

Phenotypes and Clinical Outcome of Heart Failure With Preserved Ejection Fraction Patients in China: Findings From the Chinese Cardiovascular Association Database‐Heart Failure Center Registry

MedComm, Volume 7, Issue 3, March 2026.
Structured graphical abstract‐text element Key Question It remains unclear whether patients with heart failure with preserved ejection fraction (HFpEF) in different phenotypes also have various clinical outcomes. Key Finding Significant differences existed in baseline characteristics and outcomes among different phenotypes; patients with HFpEF‐3 (right
Shuai Yuan, Zhonglei Xie, Xiaotong Cui, Shun Yao, Yamei Xu, Yanyan Wang, Yu Song, Kai Hu, Yugang Dong, Yuhua Liao, Weimin Li, Xinli Li, Jiefu Yang, Jingmin Zhou, Junbo Ge   +14 more
wiley   +1 more source

Enhancing Cardiovascular Risk Prediction in Type 2 Diabetes: The Role of NT-proBNP as a Prognostic Biomarker. [PDF]

Cureus
Hassan A, Alfauri O, Ashraf A, Nadeem L, Zaman K, Dalal AP, Raja F, Al-Omari N, Ahmad I, Safdar U, Malik MZ.   +10 more
europepmc   +1 more source

Clinical phenotypes across age groups and the predictive value of NT-proBNP for ventricular arrhythmias in left ventricular non-compaction: a multicenter cohort study. [PDF]

J Transl Med
Jiang J, Zhang X, Yang K, Kong D, Qin X, Sun Y, Xiao Y, Gu Y, Zhang B, Ma M, Tian T, Hu A.   +11 more
europepmc   +1 more source

Prognostic value of fetal growth and prenatal functional echocardiography in tetralogy of FALLOT

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 3, Page 479-491, March 2026.
First demonstration that fetal growth and pulmonary peak velocity at third trimester are independent predictors of postnatal outcome in Tetralogy of Fallot. This may enhance the accuracy of prenatal counseling and facilitate more individualized planning for delivery and neonatal care. Abstract Introduction Tetralogy of Fallot (ToF) shows variability in
Laura Nogué, Mar Bennasar, Laura Guirado, Felix Zölner, Justus Reitz, Roland Axt‐Fliedner, María C. Escobar‐Díaz, Josep Maria Martínez, Eduard Gratacós, Fàtima Crispi, Olga Gómez, for the BCNatal and Gießen and Marburg University investigators, Míriam Pérez‐Cruz, Narcís Masoller, Franziska Holland, Mireia Caballero, Marta Guilleumes, Sergi Cesar   +17 more
wiley   +1 more source